Global Glycomics/Glycobiology (Instruments, Enzymes, Kits, Reagents) Market Analysis 2017-2025 – High investments Driving the Development of New Glycobiology Tools

world news, trump, u.s., business news, stock market, entertainment news, business news, company news, market, commodities, commodity, Africa news

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]

SOURCE Research and Markets

DUBLIN, Nov. 9, 2018 /PRNewswire/ —

The “Glycomics/Glycobiology Market Analysis Report By Product (Instruments, Enzymes, Kits, Reagents), By Application (Drug Discover, Diagnostics), By End Use, By Region, And Segment Forecasts, 2018 – 2025” report has been added to’s offering.

Research and Markets Logo

The global glycomics/glycobiology market size is expected to reach USD 2.1 billion by 2025 and is anticipated to expand at a CAGR of 14.4% over the forecast period.

Rising focus on glycomics and proteomics research is driving the market. Huge investments have also enabled academic researchers to develop new glycobiology tools. This is a high-impact rendering driver for the market. As per many researchers, study on glycans helps understand biological processes more comprehensively, without specializing in glycobiology.

According to the 2017 BDO Biotech Briefing, the average R&D expenditure of mid-sized biotech companies has increased by around 18% from USD 65.9 million to USD 80.6 million during the span of 2015 to 2016. Growing drug discovery and development are leading to an increase in R&D investments by biotech companies. Thus, the need for glycomics research techniques to conduct comprehensive glycomes study is constantly growing.

Rise in number of initiatives being undertaken by the government to increase funding for research has led to the high need for glycomics techniques. For instance, the Australian government invested around USD 10 billion in scientific research and innovations for the period 2016 to 2017. The Irish Government also announced a USD 5.6 billion spending program in 2015 aimed at increasing the number of scientific research activities from 25,000 to 40,000 in the next 5 years. Such funding initiatives are expected to enhance demand for glycomics research techniques in near future.

Key players are also undertaking extensive R&D initiatives to develop new and technologically advanced products. For instance, in 2016, ProZyme, Inc. launched Gly-Q Glycan Analysis System, an integrated platform that enables user-friendly and high-throughput glycoanalysis. In 2018, Shimadzu Corporation collaborated with PREMIER Biosoft, a global player in bioinformatics solutions, with an aim to introduce its LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry system for advance glycomics and lipidomics data research analysis.

Further key findings from the report suggest:

  • Enzymes was the fastest growing product segment of the glycomics/glycobiology market in 2017, due to repetitive purchase and rising application in research and diagnostics
  • In application segment, drug discovery and development accounted for the largest revenue share in 2017, owing to high focus on novel drug development and demand for personalized medicines
  • North America is anticipated to continue to lead the global market during the forecast period owing to existence of large number of research laboratories and pharmaceutical and biotechnology companies
  • Europe is expected to expand at the highest CAGR during the forecast period due to availability of advanced infrastructure coupled with rising number of pharmaceutical and biopharmaceutical companies

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Research Methodology
2.1 Country Wise Market: Base Estimates
2.2 Global Market: CAGR Calculation
2.3 Region Based Segment Share Calculation
2.4 Research Scope & Assumptions
2.5 List of Data Sources
2.5.1 Data for primary interviews, by sources
2.5.2 Data for primary interviews, by region
2.6 Market Snapshot

Chapter 3 Glycomics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Increasing focus on glycomics and proteomics research
3.2.2 Increasing investment in R&D by research institutes and pharmaceutical & biotechnology companies
3.2.3 Technological advancements in glycomics instruments
3.3 Market Restraint Analysis
3.3.1 Stringent government policies and regulations
3.3.2 High cost of glycomics instruments
3.4 Key Opportunities Prioritized
3.5 Glycomics – SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
3.6 Industry Analysis – Porter’s

Chapter 4 Glycomics Market: Product Estimates & Trend Analysis
4.1 Glycomics Market: Product Movement Analysis
4.2 Enzymes
4.2.1 Enzymes market, 2014 – 2025 (USD Million)
4.2.2 Glycosidases
4.2.3 Glycosyltransferases
4.2.4 Neuraminidases
4.2.5 Sialyltransferases
4.2.6 Others
4.3 Kits
4.3.1 Kits market, 2014 – 2025 (USD Million)
4.3.2 Glycan labelling kits
4.3.3 Glycan purification kits
4.3.4 Glycan release kits
4.3.5 Other glycomics kits
4.4 Reagents
4.4.1 Reagents market, 2014 – 2025 (USD Million)
4.4.2 Glycoproteins
4.4.3 Monosaccharides
4.4.4 Oligosaccharides
4.4.5 Others Others market, 2014 – 2025 (USD Million)
4.5 Instruments
4.5.1 Instruments market, 2014 – 2025 (USD Million)
4.5.2 Mass spectrometers
4.5.3 HPLC
4.5.4 HPLC
4.5.6 Array systems
4.5.7 Other instruments

Chapter 5 Glycomics Market: Application Estimates & Trend Analysis
5.1 Glycomics Market: Application Movement Analysis
5.2 Drug Discovery & Development
5.3 Diagnostics
5.4 Other Applications

Chapter 6 Glycomics Market: End Use Estimates & Trend Analysis
6.1 Glycomics Market: End-Use Movement Analysis
6.2 Academic & Research Institutes
6.3 Pharmaceutical & Biotechnology Companies
6.4 Contract Research Organizations (CROs)

Chapter 7 Glycomics Market: Regional Estimates & Trend Analysis, by Product, Application, End Use
7.1 Glycomics Market Share by Region, 2014 & 2025
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.6 Middle East & Africa
7.6.1 South Africa

Chapter 8 Competitive Landscape

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Agilent Technologies
  • Bruker
  • New England Biolabs
  • Danaher
  • Shimadzu Corporation
  • Takara Bio, Inc.
  • Waters Corporation
  • ProZyme

For more information about this report visit

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:—high-investments-driving-the-development-of-new-glycobiology-tools-300747414.html

©2017 PR Newswire. All Rights Reserved.